Hims Enters Australia, Targets $1B International Revenue
HIMS has more than doubled off its 52-week low of $13.74 on light trading volume (0.3× avg).
Summary
Hims & Hers launched in Australia, its first Asia-Pacific market, by rebranding the acquired Eucalyptus men's health platform Pilot to Hims. The company expects Australia to help it reach $1B in international annual revenue within three years, citing a projected $2.56B Australian telehealth market by 2034. This follows the Eucalyptus acquisition earlier this year and comes amid recent regulatory and legal challenges, including an FTC lawsuit and Visa notice over complaints. The expansion diversifies revenue beyond the U.S. and leverages existing infrastructure, but integration and retention risks remain. Watch for early customer retention and revenue contribution from the rebranded Pilot platform in upcoming quarters.
At the time of this announcement, HIMS was trading at $29.28 on NYSE in the Life Sciences sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $13.74 to $65.30. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.